"Antigens, CD1d" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A major histocompatibility complex class I-like protein that contains an IMMUNOGLOBULIN C1-SET DOMAIN. It plays a unique role in the presentation of lipid ANTIGENS to NATURAL KILLER T-CELLS.
| Descriptor ID |
D055610
|
| MeSH Number(s) |
D23.050.301.264.035.100.500 D23.050.301.264.894.080.500 D23.101.100.110.100.500 D23.101.100.894.080.500
|
| Concept/Terms |
Antigens, CD1d- Antigens, CD1d
- CD1d Antigens
- CD1d Antigen
- Antigen, CD1d
- Cd1d Molecule
|
Below are MeSH descriptors whose meaning is more general than "Antigens, CD1d".
- Chemicals and Drugs [D]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, CD [D23.050.301.264.035]
- Antigens, CD1 [D23.050.301.264.035.100]
- Antigens, CD1d [D23.050.301.264.035.100.500]
- Antigens, Differentiation, T-Lymphocyte [D23.050.301.264.894]
- Antigens, CD1 [D23.050.301.264.894.080]
- Antigens, CD1d [D23.050.301.264.894.080.500]
- Biomarkers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, CD [D23.101.100.110]
- Antigens, CD1 [D23.101.100.110.100]
- Antigens, CD1d [D23.101.100.110.100.500]
- Antigens, Differentiation, T-Lymphocyte [D23.101.100.894]
- Antigens, CD1 [D23.101.100.894.080]
- Antigens, CD1d [D23.101.100.894.080.500]
Below are MeSH descriptors whose meaning is more specific than "Antigens, CD1d".
This graph shows the total number of publications written about "Antigens, CD1d" by people in this website by year, and whether "Antigens, CD1d" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigens, CD1d" by people in Profiles.
-
Li X, Huang J, Kawamura A, Funakoshi R, Porcelli SA, Tsuji M. Co-localization of a CD1d-binding glycolipid with an adenovirus-based malaria vaccine for a potent adjuvant effect. Vaccine. 2017 05 31; 35(24):3171-3177.
-
Li X, Kawamura A, Andrews CD, Miller JL, Wu D, Tsao T, Zhang M, Oren D, Padte NN, Porcelli SA, Wong CH, Kappe SH, Ho DD, Tsuji M. Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node-Resident Dendritic Cells for a Robust Adjuvant Effect. J Immunol. 2015 Sep 15; 195(6):2710-21.
-
Ascierto ML, Idowu MO, Zhao Y, Khalak H, Payne KK, Wang XY, Dumur CI, Bedognetti D, Tomei S, Ascierto PA, Shanker A, Bear HD, Wang E, Marincola FM, De Maria A, Manjili MH. Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients. J Transl Med. 2013 Jun 12; 11:145.
-
Chen S, Ndhlovu LC, Takahashi T, Takeda K, Ikarashi Y, Kikuchi T, Murata K, Pandolfi PP, Riccardi C, Ono M, Sugamura K, Ishii N. Co-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cells. Eur J Immunol. 2008 Aug; 38(8):2229-40.
-
Elewaut D, Shaikh RB, Hammond KJ, De Winter H, Leishman AJ, Sidobre S, Turovskaya O, Prigozy TI, Ma L, Banks TA, Lo D, Ware CF, Cheroutre H, Kronenberg M. NIK-dependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cells. J Exp Med. 2003 Jun 16; 197(12):1623-33.
-
Proc?pio DO, Almeida IC, Torrecilhas AC, Cardoso JE, Teyton L, Travassos LR, Bendelac A, Gazzinelli RT. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway. J Immunol. 2002 Oct 01; 169(7):3926-33.